Cymbalta Once-Daily Dosing Not Vital To Product's Success, Lilly Suggests
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly says it has data on twice-daily Cymbalta dosing, and analysts express concern that the company has not previously discussed the possibility of b.i.d. administration in labeling. Exec VP-Science & Technology Paul maintains Cymbalta is also "very effective and very safe" taken once a day.